Biodesix Ebit Per Revenue vs Capex To Revenue Analysis

BDSX Stock

USD 1.44 0.01 0.70%

Biodesix financial indicator trend analysis is way more than just evaluating Biodesix prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Biodesix is a good investment. Please check the relationship between Biodesix Ebit Per Revenue and its Capex To Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Ebit Per Revenue vs Capex To Revenue

Ebit Per Revenue vs Capex To Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Biodesix Ebit Per Revenue account and Capex To Revenue. At this time, the significance of the direction appears to have weak relationship.

The correlation between Biodesix's Ebit Per Revenue and Capex To Revenue is 0.32. Overlapping area represents the amount of variation of Ebit Per Revenue that can explain the historical movement of Capex To Revenue in the same time period over historical financial statements of Biodesix, assuming nothing else is changed. The correlation between historical values of Biodesix's Ebit Per Revenue and Capex To Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit Per Revenue of Biodesix are associated (or correlated) with its Capex To Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capex To Revenue has no effect on the direction of Ebit Per Revenue i.e., Biodesix's Ebit Per Revenue and Capex To Revenue go up and down completely randomly.

Correlation Coefficient

0.32

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Ebit Per Revenue

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Most indicators from Biodesix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Biodesix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biodesix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.Selling General Administrative is likely to drop to about 49.7 M in 2024. Issuance Of Capital Stock is likely to drop to about 41 M in 2024

	2023	2024 (projected)
Depreciation And Amortization	5.5M	3.2M
Interest Income	16.2K	25.9K

Depreciation And Amortization Interest Income

Biodesix fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity
Total Assets		0.46	0.72	0.9	0.96	-0.33	0.96	0.6	0.61	-0.49	-0.77	0.82	0.96	0.72	0.85	0.85	-0.05	0.96	0.88	0.93	0.94	0.57	-0.94	0.86	0.98	0.98
Short Long Term Debt Total	0.46		0.51	0.51	0.32	-0.26	0.36	0.74	-0.15	0.44	-0.63	0.27	0.22	0.85	0.66	0.66	0.81	0.22	0.44	0.57	0.43	0.62	-0.3	0.05	0.33	0.45
Other Current Liab	0.72	0.51		0.84	0.81	-0.79	0.83	0.73	0.16	-0.14	-0.87	0.27	0.59	0.82	0.78	0.78	0.1	0.59	0.42	0.92	0.87	0.65	-0.85	0.64	0.74	0.83
Total Current Liabilities	0.9	0.51	0.84		0.88	-0.37	0.88	0.63	0.57	-0.33	-0.81	0.69	0.82	0.71	0.78	0.78	-0.06	0.82	0.81	0.94	0.9	0.48	-0.88	0.83	0.9	0.9
Total Stockholder Equity	0.96	0.32	0.81	0.88		-0.54	1.0	0.62	0.51	-0.51	-0.83	0.66	0.93	0.69	0.86	0.86	-0.15	0.93	0.74	0.95	0.98	0.62	-0.99	0.88	0.97	0.98
Other Liab	-0.33	-0.26	-0.79	-0.37	-0.54		-0.55	-0.64	0.35	-0.08	0.72	0.25	-0.21	-0.63	-0.6	-0.6	-0.2	-0.21	0.12	-0.59	-0.59	-0.69	0.57	-0.23	-0.34	-0.5
Net Tangible Assets	0.96	0.36	0.83	0.88	1.0	-0.55		0.66	0.48	-0.47	-0.85	0.65	0.92	0.72	0.88	0.88	-0.11	0.92	0.73	0.96	0.99	0.65	-0.99	0.87	0.96	0.98
Property Plant And Equipment Net	0.6	0.74	0.73	0.63	0.62	-0.64	0.66		-0.18	0.35	-0.92	0.27	0.4	0.87	0.89	0.89	0.5	0.4	0.42	0.76	0.75	0.95	-0.58	0.35	0.55	0.64
Current Deferred Revenue	0.61	-0.15	0.16	0.57	0.51	0.35	0.48	-0.18		-0.82	-0.05	0.82	0.73	-0.02	0.12	0.12	-0.63	0.73	0.76	0.39	0.41	-0.26	-0.52	0.79	0.67	0.52
Net Debt	-0.49	0.44	-0.14	-0.33	-0.51	-0.08	-0.47	0.35	-0.82		-0.03	-0.52	-0.68	0.13	-0.05	-0.05	0.73	-0.68	-0.44	-0.29	-0.35	0.28	0.54	-0.68	-0.56	-0.48
Retained Earnings	-0.77	-0.63	-0.87	-0.81	-0.83	0.72	-0.85	-0.92	-0.05	-0.03		-0.36	-0.64	-0.86	-0.97	-0.97	-0.29	-0.64	-0.52	-0.91	-0.91	-0.85	0.81	-0.55	-0.73	-0.83
Accounts Payable	0.82	0.27	0.27	0.69	0.66	0.25	0.65	0.27	0.82	-0.52	-0.36		0.84	0.35	0.49	0.49	-0.22	0.84	0.97	0.6	0.62	0.22	-0.62	0.79	0.82	0.68
Cash	0.96	0.22	0.59	0.82	0.93	-0.21	0.92	0.4	0.73	-0.68	-0.64	0.84		0.5	0.73	0.73	-0.27	1.0	0.86	0.83	0.88	0.39	-0.91	0.9	0.96	0.92
Non Current Assets Total	0.72	0.85	0.82	0.71	0.69	-0.63	0.72	0.87	-0.02	0.13	-0.86	0.35	0.5		0.87	0.87	0.56	0.5	0.51	0.86	0.77	0.84	-0.68	0.41	0.65	0.77
Non Currrent Assets Other	0.85	0.66	0.78	0.78	0.86	-0.6	0.88	0.89	0.12	-0.05	-0.97	0.49	0.73	0.87		1.0	0.33	0.73	0.63	0.91	0.92	0.86	-0.82	0.56	0.78	0.87
Other Assets	0.85	0.66	0.78	0.78	0.86	-0.6	0.88	0.89	0.12	-0.05	-0.97	0.49	0.73	0.87	1.0		0.33	0.73	0.63	0.91	0.92	0.86	-0.82	0.56	0.78	0.87
Long Term Debt	-0.05	0.81	0.1	-0.06	-0.15	-0.2	-0.11	0.5	-0.63	0.73	-0.29	-0.22	-0.27	0.56	0.33	0.33		-0.27	-0.09	0.08	-0.03	0.49	0.18	-0.5	-0.21	-0.03
Cash And Short Term Investments	0.96	0.22	0.59	0.82	0.93	-0.21	0.92	0.4	0.73	-0.68	-0.64	0.84	1.0	0.5	0.73	0.73	-0.27		0.86	0.83	0.88	0.39	-0.91	0.9	0.96	0.92
Net Receivables	0.88	0.44	0.42	0.81	0.74	0.12	0.73	0.42	0.76	-0.44	-0.52	0.97	0.86	0.51	0.63	0.63	-0.09	0.86		0.72	0.72	0.32	-0.7	0.79	0.86	0.77
Good Will	0.93	0.57	0.92	0.94	0.95	-0.59	0.96	0.76	0.39	-0.29	-0.91	0.6	0.83	0.86	0.91	0.91	0.08	0.83	0.72		0.98	0.69	-0.95	0.79	0.92	0.97
Common Stock Total Equity	0.94	0.43	0.87	0.9	0.98	-0.59	0.99	0.75	0.41	-0.35	-0.91	0.62	0.88	0.77	0.92	0.92	-0.03	0.88	0.72	0.98		0.71	-0.97	0.83	0.94	0.97
Common Stock Shares Outstanding	0.57	0.62	0.65	0.48	0.62	-0.69	0.65	0.95	-0.26	0.28	-0.85	0.22	0.39	0.84	0.86	0.86	0.49	0.39	0.32	0.69	0.71		-0.57	0.31	0.52	0.61
Non Current Liabilities Total	-0.94	-0.3	-0.85	-0.88	-0.99	0.57	-0.99	-0.58	-0.52	0.54	0.81	-0.62	-0.91	-0.68	-0.82	-0.82	0.18	-0.91	-0.7	-0.95	-0.97	-0.57		-0.89	-0.95	-0.98
Inventory	0.86	0.05	0.64	0.83	0.88	-0.23	0.87	0.35	0.79	-0.68	-0.55	0.79	0.9	0.41	0.56	0.56	-0.5	0.9	0.79	0.79	0.83	0.31	-0.89		0.95	0.84
Other Current Assets	0.98	0.33	0.74	0.9	0.97	-0.34	0.96	0.55	0.67	-0.56	-0.73	0.82	0.96	0.65	0.78	0.78	-0.21	0.96	0.86	0.92	0.94	0.52	-0.95	0.95		0.96
Other Stockholder Equity	0.98	0.45	0.83	0.9	0.98	-0.5	0.98	0.64	0.52	-0.48	-0.83	0.68	0.92	0.77	0.87	0.87	-0.03	0.92	0.77	0.97	0.97	0.61	-0.98	0.84	0.96

Click cells to compare fundamentals

Biodesix Account Relationship Matchups

Biodesix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	41.6M	121.1M	76.1M	92.9M	99.1M	86.1M
Short Long Term Debt Total	36.0M	27.8M	10.0M	31.9M	60.7M	34.7M
Other Current Liab	7.4M	7.8M	25.4M	17.1M	29.6M	16.6M
Total Current Liabilities	22.6M	32.1M	29.0M	22.8M	33.4M	26.5M
Total Stockholder Equity	(228.5M)	41.2M	19.7M	20.6M	4.6M	4.8M
Other Liab	29.8M	31.9M	17.4M	19.2M	17.3M	19.8M
Net Tangible Assets	(255.3M)	12.9M	(6.9M)	(4.2M)	(4.9M)	(5.1M)
Property Plant And Equipment Net	2.1M	3.2M	4.2M	8.8M	29.6M	31.1M
Current Deferred Revenue	1.3M	3.5M	1.9M	962K	324K	307.8K
Net Debt	30.7M	(34.4M)	(22.7M)	(11.2M)	34.4M	36.1M
Retained Earnings	(230.9M)	(258.8M)	(302.0M)	(367.4M)	(419.6M)	(440.5M)
Accounts Payable	1.7M	9.0M	1.7M	1.7M	2.9M	3.3M
Cash	5.3M	62.1M	32.7M	43.1M	26.3M	32.2M
Non Current Assets Total	28.9M	34.9M	32.5M	39.6M	59.4M	41.2M
Non Currrent Assets Other	90K	3.5M	1.7M	5.9M	6.9M	7.2M
Other Assets	90K	3.5M	1.7M	5.9M	6.8M	7.2M
Long Term Debt	23.8M	15.9M	10.0M	25.0M	35.2M	24.4M
Cash And Short Term Investments	5.3M	62.1M	32.7M	43.1M	26.3M	32.2M
Net Receivables	5.3M	15.3M	3.7M	5.1M	7.7M	7.1M
Common Stock Shares Outstanding	254.9K	26.6M	27.4M	42.1M	82.1M	86.2M
Liabilities And Stockholders Equity	41.6M	121.1M	76.1M	92.9M	99.1M	86.1M
Non Current Liabilities Total	247.6M	47.8M	27.4M	49.5M	61.1M	88.8M
Inventory	800K	3.2M	2.9M	1.4M	1.6M	1.9M
Other Current Assets	2.1M	5.5M	4.3M	3.8M	4.3M	4.1M
Other Stockholder Equity	2.3M	421.0M	321.7M	387.9M	424.1M	286.9M
Total Liab	270.2M	79.9M	56.4M	72.3M	94.5M	108.0M
Net Invested Capital	(192.6M)	68.9M	29.7M	45.7M	39.9M	41.8M
Property Plant And Equipment Gross	2.1M	3.2M	4.2M	8.8M	35.2M	37.0M
Total Current Assets	12.7M	86.1M	43.6M	53.3M	39.7M	45.0M
Non Current Liabilities Other	29.5M	31.9M	17.4M	19.2M	712K	676.4K
Net Working Capital	(9.9M)	54.0M	14.7M	30.5M	6.3M	6.0M
Intangible Assets	15.1M	13.3M	11.6M	9.8M	7.9M	9.9M
Property Plant Equipment	2.1M	3.2M	4.2M	8.8M	10.1M	10.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Biodesix Ebit Per Revenue vs Capex To Revenue Analysis

Ebit Per Revenue vs Capex To Revenue

Ebit Per Revenue vs Capex To Revenue Correlation Analysis

Correlation Coefficient

Ebit Per Revenue

Capex To Revenue

Biodesix fundamental ratios Correlations

Biodesix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Biodesix fundamental ratios Accounts

Also Currently Popular

Additional Tools for Biodesix Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Tangible Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash
Other Assets	+ 1.0	Non Currrent Assets Other
Common Stock Total Equity	+ 0.99	Net Tangible Assets
Other Current Assets	+ 0.98	Total Assets
Other Stockholder Equity	+ 0.98	Total Assets

Non Current Liabilities Total	- 0.99	Net Tangible Assets
Non Current Liabilities Total	- 0.99	Total Stockholder Equity
Other Stockholder Equity	- 0.98	Non Current Liabilities Total
Non Current Liabilities Total	- 0.97	Common Stock Total Equity
Other Assets	- 0.97	Retained Earnings
Non Currrent Assets Other	- 0.97	Retained Earnings